AOA Dx

AOA Dx Employees

18 people indexed:

Abby Tyler

Head of Immunoassay R&D

fs6w.3kzgi@uv7s0.f02 Sign up to see email

j4jv.8n77w@q7sw1.nh9 Sign up to see email
Adam Cadwallader

Laboratory Manager

2ji9.z81kh6jnvii@0s83s.j7g Sign up to see email

ivn7.tsf9i49s8hq@b16k7.i1i Sign up to see email
Adele Blackler, Ph.D.

Vice President of Platform Development

j6s84.t1u31juu.1n.q@y338t.f17 Sign up to see email

tn920.4nzg2gzf.00.3@q5801.2tv Sign up to see email
Alex Fisher

Chief Operating Officer & Co-Founder

w00q.8b5v51@6j4tn.6j0 Sign up to see email

jy2p.zqnp64@81j6y.pg0 Sign up to see email
Andrea Cioffi

Director of Business Operations

8yb63g.qpyslb@zjs9w.ywh Sign up to see email

t43s63.q1jbk8@2thj2.105 Sign up to see email
Anna Jeter

Chief Regulatory Officer & Co-Founder

yvyf.wpz9v@lf06q.pkp Sign up to see email

gbb8.8yy1v@hs68u.zuq Sign up to see email
Chloe Talley

Clinical Trial Associate

5gfkv.fjkg2z@pu18z.4fg Sign up to see email

u7q6r.74s839@p95kg.vk9 Sign up to see email
Elizabeth Yarber

Senior Director of Clinical Operations

vs0w4ksfg.wf6k5j@pu544.2qs Sign up to see email

g9p1qu672.s997wu@w9kjv.9uf Sign up to see email
Enkhtuya Radnaa, Ph.D.

Immunoassay Scientist

b36wvs9s.0v50jq.w8.5@8q5l9.jil Sign up to see email

2zglg53l.j9g728.32.w@zvg5j.99g Sign up to see email
Jeanne Jones

Senior Clinical Project Manager

f995yw.6l6rh@wthhi.72g Sign up to see email

bfgp23.uvlt5@40trb.lq7 Sign up to see email
Lindsey Kemp

Clinical Trial Associate

huj510z.06tw@555z0.01b Sign up to see email

1fuvfvz.r1bz@50fbr.zhq Sign up to see email
Maria Wong

Laboratory Technician

36fej.fzq2@23z82.7bv Sign up to see email

2q993.fh3p@q7869.tpu Sign up to see email
Mattie Goldberg

Project Manager

kp2qv7.w4fn1h5v@53qju.kw1 Sign up to see email

q3sjk6.pyk60wsp@0v90s.493 Sign up to see email
Megan Miller-Awe

Laboratory Technician

2jf3j.5f3k6pyz7z@fft09.95z Sign up to see email

2f8u4.818st13410@uk3hy.97f Sign up to see email
Michael Matthews

Senior Clinical Trial Specialist

vr2pfkf.vf0ny010@1nr31.46q Sign up to see email

60z7j1n.r01q3vv1@5pfg1.qpf Sign up to see email
Oriana Papin-Zoghbi

Chief Executive Officer & Co-Founder

sezl85@qhw0b.wg3 Sign up to see email

zpw5gg@4py8v.4uv Sign up to see email
Rachel Culp-Hill, Ph.D.

Mass Spectrometry Scientist

z1k87q.tsnnf0ybg.3j.3@02jyn.1t7 Sign up to see email

jj8678.zfkzn371s.kj.f@tk2n2.628 Sign up to see email
Robert Law, Ph.D.

Senior Immunoassay Scientist

k7vnnz.j5s.74.g@kf7yk.9qv Sign up to see email

u28g4j.9iq.in.0@u4kkq.z51 Sign up to see email

AOA Dx Company Information

AOA Dx, formerly known as AOA Dx Inc., is a pioneering healthcare company based in New York, NY, and Cambridge, MA, with additional remote operations. The company, which is part of the Y Combinator S21 batch, operates within the diagnostics sub-industry of healthcare and is dedicated to advancing women’s health through the development of early cancer detection technologies. AOA Dx has developed GlycoLocate™, a revolutionary tumor marker ganglioside platform, and AKRIVIS GD™, a novel blood test that utilizes tumor marker gangliosides for the early detection of ovarian cancer. The company has partnered with leading researchers at McGill University to develop these technologies and has completed a retrospective patient study involving over 500 participants, demonstrating high sensitivity and specificity in its tests. AOA Dx has raised a $7 million seed round and continues to offer career opportunities for individuals dedicated to making significant advancements in early cancer detection.

Report inaccurate information